Profile
Volker Knappertz occupies the position of Chief Medical Officer for GW Pharmaceuticals Plc. Dr. Knappertz previously occupied the position of Vice President-Clinical Development at Teva Pharmaceuticals Ltd. Dr. Knappertz received a doctorate from Universität zu Köln.
Volker Knappertz active positions
| Companies | Position | Start |
|---|---|---|
Sutura Therapeutics Ltd.
Sutura Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company developing peptide bio molecular medicinal products | Director/Board Member | 31/08/2021 |
Former positions of Volker Knappertz
| Companies | Position | End |
|---|---|---|
| GW PHARMACEUTICALS PLC | Chief Tech/Sci/R&D Officer | 31/12/2021 |
Teva Pharmaceuticals Ltd.
Teva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Corporate Officer/Principal | 30/04/2017 |
| AURINIA PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | - |
Training of Volker Knappertz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
GW Pharmaceuticals Ltd.
GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets novel therapeutics | Health Technology |
Universität zu Köln
Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Teva Pharmaceuticals Ltd.
Teva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Aurinia Pharmaceuticals, Inc.
Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Sutura Therapeutics Ltd.
Sutura Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company developing peptide bio molecular medicinal products | Commercial Services |
- Stock Market
- Insiders
- Volker Knappertz
















